No Data
AstraZeneca Plans $2 Billion New Investment in U.S.
Astrazeneca (AZN.US) submits potential blockbuster ADC therapy for FDA approval.
AstraZeneca (AZN.US) has submitted a potential blockbuster ADC therapy for FDA approval.
AstraZeneca Reports Strong Growth in Q3 2024
Astrazeneca (AZN.US) and Merck (MRK.US) jointly announced the positive top-line results of the KOMET phase 3 clinical trial.
Today, Astrazeneca (AZN.US) and Merck (MRK.US) jointly announced the positive top-line results of the phase 3 KOMET clinical trial.
AstraZeneca PLC (AZN) Q3 2024 Earnings Call Transcript Summary
AstraZeneca PLC (AZN) Q3 2024 Earnings Call Transcript
defishu : Low enough, right?
102875548 OP defishu : AstraZeneca shares fall as China probe intensifies
astra fell 8% in UK market